GlassScriptPhysician profile
Craig R Ruble
NPI 1467402867
$2,441.09
in general payments reported to CMS, 2019-2025
31 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $568 · 2021: $423 · 2022: $223 · 2023: $158 · 2024: $238 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $320.26 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $264.01 | 2021-2024 | Persona, Mymobility Platform, Rosa |
| Pacira Therapeutics, INC. | $255.37 | 2019-2021 | |
| Amgen INC. | $159.90 | 2021-2022 | |
| Microport Orthopedics INC | $130.81 | 2019 | |
| Elite Orthopedics, LLC | $121.21 | 2021-2025 | |
| Smith+Nephew, INC. | $112.58 | 2019-2025 | Pico 14, Pico |
| Stryker Corporation | $108.33 | 2020-2025 | Aequalis Perform Reversed |
| Depuy Synthes Sales INC. | $96.79 | 2019-2025 | Dynacord, Healix Knotless Peek, Truespan Orthocord |
| Ferring Pharmaceuticals INC. | $88.92 | 2020-2025 | Euflexxa |
| Pacira Pharmaceuticals Incorporated | $88.70 | 2020-2024 | Zilretta, Exparel, Iovera |
| Bioventus LLC | $85.71 | 2019-2023 | Durolane |
| Paratek Pharmaceuticals, INC. | $83.95 | 2025 | Nuzyra |
| Zyla Life Sciences, INC. | $72.73 | 2019-2020 | |
| Convatec INC. | $64.07 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $56.05 | 2020-2022 | |
| Vertex Pharmaceuticals Incorporated | $47.42 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $36.66 | 2020 | |
| Assertio Therapeutics, INC. | $30.73 | 2020 | |
| Axogen | $25.63 | 2020 | |
| Acera Surgical, INC. | $23.25 | 2024 | Restrata Wound Matrix |
| Endo USA, INC. | $22.28 | 2025 | Xiaflex |
| Fidia Pharma USA INC. | $21.98 | 2020 | |
| Davol INC. | $21.65 | 2023 | Arista Ah Flexitip |
| Abbott Laboratories | $17.88 | 2023 | Proclaim |
| Sanofi-Aventis U.S. LLC | $17.47 | 2019 | |
| Baudax Bio INC. | $14.88 | 2021 | |
| Iroko Pharmaceuticals, LLC | $14.27 | 2019 | |
| Motive Health, INC. | $13.68 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.06 | 2022 | |
| Heron Therapeutics, INC. | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Ruble listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.